[1]
Rodriguez Arroyo, B.P. et al. 2024. Partial response to treatment with ALK inhibitor in a patient with SQSTM1-ALK fusion positive lung adenocarcinoma. European Journal of Case Reports in Internal Medicine. 11, 12 (Nov. 2024). DOI:https://doi.org/10.12890/2024_004887.